InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Egeland Ryan, Directeur Médical. Director active across 1 company, notably Cardiovascular Systems Inc. Aggregated, 4 filings have been recorded. Activity tracked since 9 August 2021. The latest transaction was disclosed on 8 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Ryan Egeland is the Chief Medical Officer at Cardiovascular Systems Inc. He is responsible for the medical direction and innovation in the development of medical devices for the treatment of cardiovascular diseases. Ryan brings valuable clinical expertise to guide the company's research and development initiatives.